{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:51:48Z","timestamp":1788897108886,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,10]]},"DOI":"10.7759\/cureus.64241","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:58:56Z","timestamp":1720619936000},"source":"Crossref","is-referenced-by-count":1,"title":["The Effects of Subcutaneous Rapid-Acting Insulin Aspart in the Treatment of Mild and Moderate Diabetic Ketoacidosis in Children: A Prospective Study"],"prefix":"10.7759","author":[{"given":"Hanieh","family":"Talebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2022.101418","article-title":"Diabetic ketoacidosis","volume":"69","author":"Calimag AP","year":"2023","unstructured":"Calimag AP, Chlebek S, Lerma EV, Chaiban JT. Diabetic ketoacidosis. Dis Mon. 2023, 69:101418. 10.1016\/j.disamonth.2022.101418","journal-title":"Dis Mon"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2010.31","article-title":"Frequency of ketoacidosis in newly diagnosed type 1 diabetic children","volume":"25","author":"Razavi Z","year":"2010","unstructured":"Razavi Z. Frequency of ketoacidosis in newly diagnosed type 1 diabetic children. Oman Med J. 2010, 25:114-7. 10.5001\/omj.2010.31","journal-title":"Oman Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_478_19","article-title":"Management of diabetic ketoacidosis in adults: a narrative review","volume":"8","author":"Eledrisi MS","year":"2020","unstructured":"Eledrisi MS, Elzouki AN. Management of diabetic ketoacidosis in adults: a narrative review. Saudi J Med Med Sci. 2020, 8:165-73. 10.4103\/sjmms.sjmms_478_19","journal-title":"Saudi J Med Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12701","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state","volume":"19 Suppl 27","author":"Wolfsdorf JI","year":"2018","unstructured":"Wolfsdorf JI, Glaser N, Agus M, et al.. ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018, 19 Suppl 27:155-77. 10.1111\/pedi.12701","journal-title":"Pediatr Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-070131","article-title":"Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials","volume":"13","author":"Lim BL","year":"2023","unstructured":"Lim BL, Lee WF, Lee B, Chung YE, Loo KV. Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials. BMJ Open. 2023, 13:e070131. 10.1136\/bmjopen-2022-070131","journal-title":"BMJ Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2577","article-title":"Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state","volume":"93","author":"Kitabchi AE","year":"2008","unstructured":"Kitabchi AE, Umpierrez GE, Fisher JN, Murphy MB, Stentz FB. Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab. 2008, 93:1541-52. 10.1210\/jc.2007-2577","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1751143716644458","article-title":"Incidence and long-term outcomes of adult patients with diabetic ketoacidosis admitted to intensive care: A retrospective cohort study","volume":"17","author":"Ramaesh A","year":"2016","unstructured":"Ramaesh A. Incidence and long-term outcomes of adult patients with diabetic ketoacidosis admitted to intensive care: A retrospective cohort study. J Intensive Care Soc. 2016, 17:222-33. 10.1177\/1751143716644458","journal-title":"J Intensive Care Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac301","article-title":"Potential role of ultrafast-acting insulin analogues in the treatment of diabetic ketoacidosis","volume":"107","author":"Koufakis T","year":"2022","unstructured":"Koufakis T, Dhatariya KK, Kotsa K. Potential role of ultrafast-acting insulin analogues in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab. 2022, 107:e4259-60. 10.1210\/clinem\/dgac301","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi AE","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009, 32:1335-43. 10.2337\/dc09-9032","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2008.07.023","article-title":"Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?","volume":"53","author":"Mazer M","year":"2009","unstructured":"Mazer M, Chen E. Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?. Ann Emerg Med. 2009, 53:259-63. 10.1016\/j.annemergmed.2008.07.023","journal-title":"Ann Emerg Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12380","article-title":"Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children","volume":"18","author":"Cohen M","year":"2017","unstructured":"Cohen M, Leibovitz N, Shilo S, Zuckerman-Levin N, Shavit I, Shehadeh N. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children. Pediatr Diabetes. 2017, 18:290-6. 10.1111\/pedi.12380","journal-title":"Pediatr Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2021-0527","article-title":"Subcutaneous regular insulin use for the management of diabetic ketoacidosis in resource limited setting","volume":"35","author":"Yismaw BF","year":"2022","unstructured":"Yismaw BF, Leulseged TW. Subcutaneous regular insulin use for the management of diabetic ketoacidosis in resource limited setting. J Pediatr Endocrinol Metab. 2022, 35:179-84. 10.1515\/jpem-2021-0527","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13118","article-title":"ISPAD Clinical Practice Consensus Guideline: diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin","volume":"21","author":"Priyambada L","year":"2020","unstructured":"Priyambada L, Wolfsdorf JI, Brink SJ, Fritsch M, Codner E, Donaghue KC, Craig ME. ISPAD Clinical Practice Consensus Guideline: diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin. Pediatr Diabetes. 2020, 21:1394-402. 10.1111\/pedi.13118","journal-title":"Pediatr Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2013.01.014","article-title":"New approaches to the use of insulin in patients with diabetic ketoacidosis","volume":"24","author":"Barski L","year":"2013","unstructured":"Barski L, Kezerle L, Zeller L, Zektser M, Jotkowitz A. New approaches to the use of insulin in patients with diabetic ketoacidosis. Eur J Intern Med. 2013, 24:213-6. 10.1016\/j.ejim.2013.01.014","journal-title":"Eur J Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2015.05.016","article-title":"Does management of diabetic ketoacidosis with subcutaneous rapid-acting insulin reduce the need for intensive care unit admission?","volume":"49","author":"Cohn BG","year":"2015","unstructured":"Cohn BG, Keim SM, Watkins JW, Camargo CA. Does management of diabetic ketoacidosis with subcutaneous rapid-acting insulin reduce the need for intensive care unit admission?. J Emerg Med. 2015, 49:530-8. 10.1016\/j.jemermed.2015.05.016","journal-title":"J Emerg Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S194944","article-title":"Fluid therapy for pediatric patients with diabetic ketoacidosis: current perspectives","volume":"12","author":"Jayashree M","year":"2019","unstructured":"Jayashree M, Williams V, Iyer R. Fluid therapy for pediatric patients with diabetic ketoacidosis: current perspectives. Diabetes Metab Syndr Obes. 2019, 12:2355-61. 10.2147\/DMSO.S194944","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.2951150","article-title":"Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association","volume":"29","author":"Wolfsdorf J","year":"2006","unstructured":"Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care. 2006, 29:1150-9. 10.2337\/diacare.2951150","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2683-3","article-title":"0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial","volume":"24","author":"Williams V","year":"2020","unstructured":"Williams V, Jayashree M, Nallasamy K, Dayal D, Rawat A. 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial. Crit Care. 2020, 24:1. 10.1186\/s13054-019-2683-3","journal-title":"Crit Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2012.12.003","article-title":"Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies","volume":"39","author":"Vincent M","year":"2013","unstructured":"Vincent M, Nob\u00e9court E. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies. Diabetes Metab. 2013, 39:299-305. 10.1016\/j.diabet.2012.12.003","journal-title":"Diabetes Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2006.00786.x","article-title":"Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients","volume":"60","author":"Ers\u00f6z HO","year":"2006","unstructured":"Ers\u00f6z HO, Ukinc K, K\u00f6se M, Erem C, Gunduz A, Hacihasanoglu AB, Karti SS. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract. 2006, 60:429-33. 10.1111\/j.1368-5031.2006.00786.x","journal-title":"Int J Clin Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011281.pub2","article-title":"Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis","volume":"2016","author":"Andrade-Castellanos CA","year":"2016","unstructured":"Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016, 2016:CD011281. 10.1002\/14651858.CD011281.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1635-z","article-title":"Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients","volume":"61","author":"Razavi Z","year":"2018","unstructured":"Razavi Z, Maher S, Fredmal J. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients. Endocrine. 2018, 61:267-74. 10.1007\/s12020-018-1635-z","journal-title":"Endocrine"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.30043","article-title":"Estimated cost-effectiveness of subcutaneous insulin aspart in the management of mild diabetic ketoacidosis among children","volume":"5","author":"Bali IA","year":"2022","unstructured":"Bali IA, Al-Jelaify MR, AlRuthia Y, Mulla JZ, Amlih DF, Bin Omair AI, Al Khalifah RA. Estimated cost-effectiveness of subcutaneous insulin aspart in the management of mild diabetic ketoacidosis among children. JAMA Netw Open. 2022, 5:e2230043. 10.1001\/jamanetworkopen.2022.30043","journal-title":"JAMA Netw Open"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30721","article-title":"Efficacy and safety of intravenous insulin in treatment of patient with diabetic ketoacidosis: a systematic review and meta-analysis","volume":"14","author":"Alshurtan KS","year":"2022","unstructured":"Alshurtan KS, Alnizari O, Aldarwish H, Al-Tufaif AA. Efficacy and safety of intravenous insulin in treatment of patient with diabetic ketoacidosis: a systematic review and meta-analysis. Cureus. 2022, 14:e30721. 10.7759\/cureus.30721","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-023-05878-1","article-title":"Incidence, predictors, and short-term outcomes of acute kidney injury in children with diabetic ketoacidosis: a systematic review","volume":"38","author":"Meena J","year":"2023","unstructured":"Meena J, Yadav J, Kumar J, et al.. Incidence, predictors, and short-term outcomes of acute kidney injury in children with diabetic ketoacidosis: a systematic review. Pediatr Nephrol. 2023, 38:2023-31. 10.1007\/s00467-023-05878-1","journal-title":"Pediatr Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1563542","article-title":"Psychological aspects of care of the critically ill child","volume":"4","author":"Colville GA","year":"2015","unstructured":"Colville GA. Psychological aspects of care of the critically ill child. J Pediatr Intensive Care. 2015, 4:182-7. 10.1055\/s-0035-1563542","journal-title":"J Pediatr Intensive Care"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-004-2310-9","article-title":"Psychiatric outcome following paediatric intensive care unit (PICU) admission: a cohort study","volume":"30","author":"Rees G","year":"2004","unstructured":"Rees G, Gledhill J, Garralda ME, Nadel S. Psychiatric outcome following paediatric intensive care unit (PICU) admission: a cohort study. Intensive Care Med. 2004, 30:1607-14. 10.1007\/s00134-004-2310-9","journal-title":"Intensive Care Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.iccn.2021.103089","article-title":"Parents' experiences during and after their child's stay in the paediatric intensive care unit - a qualitative interview study","volume":"67","author":"Jakobsen L","year":"2021","unstructured":"Jakobsen L, Kristensen KK, Laerkner E. Parents' experiences during and after their child's stay in the paediatric intensive care unit - a qualitative interview study. Intensive Crit Care Nurs. 2021, 67:103089. 10.1016\/j.iccn.2021.103089","journal-title":"Intensive Crit Care Nurs"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.5767","article-title":"Assessment of long-term psychological outcomes after pediatric intensive care unit admission: a systematic review and meta-analysis","volume":"176","author":"Ko MS","year":"2022","unstructured":"Ko MS, Poh PF, Heng KY, Sultana R, Murphy B, Ng RW, Lee JH. Assessment of long-term psychological outcomes after pediatric intensive care unit admission: a systematic review and meta-analysis. JAMA Pediatr. 2022, 176:e215767. 10.1001\/jamapediatrics.2021.5767","journal-title":"JAMA Pediatr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-4159-5","article-title":"Circulating phthalates during critical illness in children are associated with long-term attention deficit: a study of a development and a validation cohort","volume":"42","author":"Verstraete S","year":"2016","unstructured":"Verstraete S, Vanhorebeek I, Covaci A, G\u00fciza F, Malarvannan G, Jorens PG, Van den Berghe G. Circulating phthalates during critical illness in children are associated with long-term attention deficit: a study of a development and a validation cohort. Intensive Care Med. 2016, 42:379-92. 10.1007\/s00134-015-4159-5","journal-title":"Intensive Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/265959-the-effects-of-subcutaneous-rapid-acting-insulin-aspart-in-the-treatment-of-mild-and-moderate-diabetic-ketoacidosis-in-children-a-prospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:59:04Z","timestamp":1720619944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/265959-the-effects-of-subcutaneous-rapid-acting-insulin-aspart-in-the-treatment-of-mild-and-moderate-diabetic-ketoacidosis-in-children-a-prospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.64241","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,10]]}}}